from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2504c/scoA

LFCtreatmentdescriptionclass of inhibitor

0.172

Amikacinug/mL Amikacintranslation

0.210

Cap5-10ug/mL Capreomycintranslation

1.348

Rox10-50 ug/mL Roxithromycintranslation

-0.287

SM2-5 ug/mL Streptomycintranslation

-0.417

Tet5-10 ug/mL Tetracyclinetranslation

-0.487

Rif0.2-5ug/mL Rifampicintranscription

-0.633

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.368

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.914

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.480

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.077

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.279

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.200

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.646

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.622

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.406

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.133

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.851

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.880

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.866

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.934

KCN5-20 ug/mL Potassium cyaniderespiration

-0.715

NaN30.2-2 mM Sodium aziderespiration

1.218

Nigericin50 uM Nigericinrespiration

0.701

TRC10-150 ug/mL Triclosanrespiration

1.499

TRZ10-25 ug/mL Thioridazinerespiration

1.268

Valinomycin0.5-10 uM Valinomycinrespiration

-0.203

ZnSO42 mM ZnSO4respiration

-1.025

menadione6-10 ug/mL Menadionerespiration

-0.219

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.476

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.254

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.448

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.405

NRP_1Non-replicating persistence stage 1dosRassociated

-0.743

Amp0.2mg/mL AmpicillincellWall

-0.596

Cephalexin20-100 ug/mL CephalexincellWall

-0.610

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.521

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.728

EMB10-20 ug/mL EthambutolcellWall

-0.700

Eta12-40 ug/mL EthionamidecellWall

-0.620

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.606

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.148

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.281

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.351

BZA0.12 mg/mL BenzamidearomaticAmides

0.464

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.506

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.174

H2O24 mM hydrogen peroxideDNAdamaging

-0.449

Levo10 ug/mL LevofloxacinDNAdamaging

-0.155

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.163

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.581

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.183

UVUV-irradiationDNAdamaging

-0.982

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.172

Antimycin12.5-50 ug/mL Antimycin A?

-0.592

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.786

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.774

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.863

PA8240.2-2 ug/mL PA-824?

-0.890

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.724

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.478

Verapamil50 uM Verapamil?

-0.498

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.711

methoxatin10-20 ug/mL Methoxatin?